American Journal of Medical Genetics · 1999 · 81 citations · 11 references
Life SciencesGeneticsMolecular GeneticsAutism Spectrum DisordersHuman GeneticsMedical GeneticsAutism Spectrum Disorder GeneticsGenetic DisordersNeurodevelopmental DisordersNeurodevelopmental GeneticsNeurogenetic DisordersPsychiatric GeneticsAllele FrequencyAllele SegregationDisorderNeurofibromatosis Type 1
Neurofibromatosis type 1 (NF1) is increased about 150-fold in autistic patients. The aim of this study was to test for an association between the NF1 locus and autistic disorder. The allele distributions of three markers of the NF1 gene were studied in 85 autistic patients and 90 controls. No differences in allele distributions were observed. However, we found a new allele (allele 5) of the GXAlu marker in four autistic patients. Allele 5 was absent in a larger control population (213 individuals). The patients with allele 5 had a more severe clinical picture, mainly in the fields of motility and tonus. Our preliminary results suggest that the NF1 region is not a major susceptibility locus for autism. However, the GXAlu marker of the NF1 gene appears as a possible candidate for a susceptibility locus in a small subgroup of severely affected autistic patients. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 88:729-732, 1999.
11
Anthony Bailey, Amaia Hervás, Nicola Matthews et al. · Human Molecular Genetics · 1998 · 540 citations · Full text
An Alu polymorphism intragenic to the neurofibromatosis type 1 gene (NF1)
Gangfeng Xu, Lesa Nelson, P. O’Connell et al. · Nucleic Acids Research · 1991 · 98 citations · Full text